FDA: Do not use Texas compounder鈥檚 products intended as sterile
Health care providers should not use products intended as sterile made by North American Custom Laboratories LLC, FarmaKeio Superior Custom Compounding in Richardson, Texas, because the products may not be sterile, the Food and Drug Administration yesterday. Administering a non-sterile drug intended as sterile may result in life-threatening consequences, including infections and sepsis. FDA was not aware of any illness associated with using the drugs. The agency recommends providers and patients report unexpected side effects or quality problems associated with the drugs to its .
Related News Articles
Headline
The Food and Drug Administration today issued an alert on a potentially high-risk issue with Calyxo CVAC Aspiration Systems. In patients who have thick fluid鈥
Headline
In this conversation, Carlos Roberts, M.D., urogynecologist, vice president and chief medical officer of the Women and Children service line at WellSpan Health鈥
Headline
In this 鈥淪afety Speaks鈥 conversation, CommonSpirit Health's Beth Miller, system director, patient safety-performance improvement, and Austin Peterson, system鈥
Headline
The Food and Drug Administration Feb. 23 withdrew approval of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S.鈥
Headline
AHA today submitted comments on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an鈥
Headline
Abbott has recalled certain lots of its Dragonfly OpStar imaging catheter because a marker band may separate from the catheter and remain in the patient after鈥